These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23816940)

  • 21. Pulmonary neuroendocrine tumor incidentally detected by (18)F-CH PET/CT.
    Treglia G; Lococo F; Petrone G; Inzani F; Perotti G; Porziella V; Granone P; Rindi G; Giordano A; Rufini V
    Clin Nucl Med; 2013 Apr; 38(4):e196-9. PubMed ID: 23446117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An unusual case of thymic carcinoid causing Cushing's syndrome due to ectopic ACTH secretion detected by (18)F-FDG PET/CT.
    Treglia G; Giovanella L; Lococo F; Bertagna F
    Rev Esp Med Nucl Imagen Mol; 2014; 33(4):253-4. PubMed ID: 24388589
    [No Abstract]   [Full Text] [Related]  

  • 23. A rare case of synchronous bilateral pulmonary neuroendocrine tumor detected by 68Ga-DOTANOC PET/CT.
    Taralli S; Treglia G; Perotti G; Graziano P; Cardillo G; Castaldi P; Calcagni ML; Rufini V; Giordano A
    Clin Nucl Med; 2012 Apr; 37(4):e91-4. PubMed ID: 22391733
    [No Abstract]   [Full Text] [Related]  

  • 24. The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors.
    Frilling A; Sotiropoulos GC; Radtke A; Malago M; Bockisch A; Kuehl H; Li J; Broelsch CE
    Ann Surg; 2010 Nov; 252(5):850-6. PubMed ID: 21037441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioguided surgery in patient with pancreatic neuroendocrine tumour followed by PET/CT scan as a new approach of complete resection evaluation--case report.
    Kunikowska J; Słodkowski M; Koperski Ł; Kolasa A; Maryański J; Pawliszak P; Matyskiel R; Chojnowski M; Najdzik M; Królicki L
    Nucl Med Rev Cent East Eur; 2014; 17(2):110-4. PubMed ID: 25088113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
    Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
    Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
    J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation.
    Imperiale A; Rust E; Gabriel S; Detour J; Goichot B; Duclos B; Kurtz JE; Bachellier P; Namer IJ; Taïeb D
    J Nucl Med; 2014 Mar; 55(3):367-72. PubMed ID: 24343986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 68Ga-DOTATATE PET/CT of ACTH-Independent Cushing Syndrome Due to Ectopic Adrenocortical Adenoma.
    Jiang Y; Liu Q; Zhu Z
    Clin Nucl Med; 2023 Jan; 48(1):83-84. PubMed ID: 36469068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
    Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
    ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ⁶⁸Ga-DOTANOC PET/CT in patients with carcinoma of unknown primary of neuroendocrine origin.
    Naswa N; Sharma P; Kumar A; Soundararajan R; Kumar R; Malhotra A; Ammini AC; Bal C
    Clin Nucl Med; 2012 Mar; 37(3):245-51. PubMed ID: 22310250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rare case of neuroendocrine tumor of the middle ear detected by gallium-68-DOTANOC-PET/CT.
    Treglia G; Baldelli R; Cristalli G; Visca P; Barnabei A; Rufini V; Appetecchia M
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1319-20. PubMed ID: 23401045
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT.
    Haug AR; Cindea-Drimus R; Auernhammer CJ; Reincke M; Beuschlein F; Wängler B; Uebleis C; Schmidt GP; Spitzweg C; Bartenstein P; Hacker M
    Radiology; 2014 Feb; 270(2):517-25. PubMed ID: 24056402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours.
    Hofman MS; Kong G; Neels OC; Eu P; Hong E; Hicks RJ
    J Med Imaging Radiat Oncol; 2012 Feb; 56(1):40-7. PubMed ID: 22339744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.
    Etchebehere EC; de Oliveira Santos A; Gumz B; Vicente A; Hoff PG; Corradi G; Ichiki WA; de Almeida Filho JG; Cantoni S; Camargo EE; Costa FP
    J Nucl Med; 2014 Oct; 55(10):1598-604. PubMed ID: 25168627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome.
    Markou A; Manning P; Kaya B; Datta SN; Bomanji JB; Conway GS
    Eur J Endocrinol; 2005 Apr; 152(4):521-5. PubMed ID: 15817906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography.
    Orlefors H; Sundin A; Garske U; Juhlin C; Oberg K; Skogseid B; Langstrom B; Bergstrom M; Eriksson B
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3392-400. PubMed ID: 15755858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome.
    Tabarin A; Valli N; Chanson P; Bachelot Y; Rohmer V; Bex-Bachellerie V; Catargi B; Roger P; Laurent F
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1193-202. PubMed ID: 10199752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of PET/CT in the functional imaging of endocrine pancreatic tumors.
    Rufini V; Baum RP; Castaldi P; Treglia G; De Gaetano AM; Carreras C; Kaemmerer D; Hommann M; Hörsch D; Bonomo L; Giordano A
    Abdom Imaging; 2012 Dec; 37(6):1004-20. PubMed ID: 22422069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.
    Kayani I; Bomanji JB; Groves A; Conway G; Gacinovic S; Win T; Dickson J; Caplin M; Ell PJ
    Cancer; 2008 Jun; 112(11):2447-55. PubMed ID: 18383518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.